BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2694236)

  • 1. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.
    Harrison NK; Glanville AR; Strickland B; Haslam PL; Corrin B; Addis BJ; Lawrence R; Millar AB; Black CM; Turner-Warwick M
    Respir Med; 1989 Sep; 83(5):403-14. PubMed ID: 2694236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM
    Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
    Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
    Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis.
    Wells AU; Hansell DM; Harrison NK; Lawrence R; Black CM; du Bois RM
    Eur Respir J; 1993 Jun; 6(6):797-802. PubMed ID: 8339797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of inhaled technetium-99m-DTPA as a clinical index of pulmonary vascular disease in systemic sclerosis.
    Kon OM; Daniil Z; Black CM; du Bois RM
    Eur Respir J; 1999 Jan; 13(1):133-6. PubMed ID: 10836337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
    Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
    Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
    Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
    De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
    Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
    Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
    Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis.
    Antoniou KM; Malagari K; Tzanakis N; Perisinakis K; Symvoulakis EK; Karkavitsas N; Siafakas NM; Bouros D
    BMC Pulm Med; 2006 Feb; 6():4. PubMed ID: 16483363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
    Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis.
    Schmekel B; Wollmer P; Venge P; Linden M; Blom-Bülow B
    Thorax; 1990 Jul; 45(7):525-9. PubMed ID: 2168589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early pulmonary involvement in systemic sclerosis assessed by technetium-99m-DTPA clearance rate.
    Fanti S; De Fabritiis A; Aloisi D; Dondi M; Marengo M; Compagnone G; Fallani F; Cavalli A; Monetti N
    J Nucl Med; 1994 Dec; 35(12):1933-6. PubMed ID: 7989973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.
    Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G
    Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
    Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.
    Clements PJ; Goldin JG; Kleerup EC; Furst DE; Elashoff RM; Tashkin DP; Roth MD
    Arthritis Rheum; 2004 Jun; 50(6):1909-17. PubMed ID: 15188367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioaerosol lung clearance in patients with active pulmonary sarcoidosis.
    Jacobs MP; Baughman RP; Hughes J; Fernandez-Ulloa M
    Am Rev Respir Dis; 1985 May; 131(5):687-9. PubMed ID: 4003915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease.
    Kumánovics G; Zibotics H; Juhász E; Komócsi A; Czirják L
    Clin Exp Rheumatol; 2001; 19(5):551-9. PubMed ID: 11579714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
    Giacomelli R; Valentini G; Salsano F; Cipriani P; Sambo P; Conforti ML; Fulminis A; De Luca A; Farina G; Candela M; Generini S; De Francisci A; Tirri E; Proietti M; Bombardieri S; Gabrielli A; Tonietti G; Cerinic MM
    J Rheumatol; 2002 Apr; 29(4):731-6. PubMed ID: 11950014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.